🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

ADORA2A

MOLECULAR TARGET

adenosine A2a receptor

UniProt: P30543NCBI Gene: 2536948 compounds

ADORA2A (adenosine A2a receptor) is targeted by 48 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADORA2A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tamoxifen5.88358
2nifedipine5.34208
3allopurinol5.04154
4sb 2035804.92136
5neca4.86128
6sildenafil4.78118
7raloxifene4.77117
813 dipropyl 8 cyclopentylxanthine dpcpx4.5796
9galangin4.3073
10n6 cyclopentyladenosine4.2871
11sr mefloquine4.2871
12diethylstilbestrol4.0657
13gentian violet4.0355
14ib meca4.0154
15amiloride3.9551
16namodenoson3.9551
17zm 2413853.8747
18cgs 216803.6638
19s dhpa3.6437
20istradefylline3.5032
21cgs 159433.4731
22r pia3.4731
23sch 582613.4029
24xanthine amine congener3.3728
258 phenyl theophylline3.2625
26imiquimod3.1422
27enprofylline2.9418
282-Chloroadenosine 2-Chloroadenosine.2.8917
29bithionol2.8917
30psilocin2.7715
31rolofylline2.7114
32nn hexamethyleneamiloride2.5612
33defactinib2.4811
34gsk0462.4010
35s pia2.4010
36trioxsalen2.309
37Adenosine2.208
38regadenoson anhydrous2.208
39metrifudil2.208
40tozadenant2.087
41ciforadenant1.956
42tecadenoson1.956
43Caffeine1.795
44rs mefloquine1.795
45st15351.795
46binodenoson1.795
47Apigenin 5,7,4'-trihydroxy-flavone,0.691
48Quercetin0.691

About ADORA2A as a Drug Target

ADORA2A (adenosine A2a receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 48 compounds with documented ADORA2A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADORA2A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.